Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Assets (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Return on Assets data on record, last reported at 0.03% in Q4 2025.

  • For Q4 2025, Return on Assets rose 10.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.03%, up 10.0%, while the annual FY2025 figure was 0.03%, 10.0% up from the prior year.
  • Return on Assets reached 0.03% in Q4 2025 per MIRM's latest filing, up from 0.05% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.03% in Q4 2025 and bottomed at 0.74% in Q3 2021.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.24% recorded in 2022.
  • Peak YoY movement for Return on Assets: soared 61bps in 2022, then fell -27bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.32% in 2021, then fell by -19bps to 0.38% in 2022, then soared by 33bps to 0.25% in 2023, then surged by 48bps to 0.13% in 2024, then skyrocketed by 78bps to 0.03% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.03% in Q4 2025, 0.05% in Q3 2025, and 0.08% in Q2 2025.